Back to all bills
HR 1620119th CongressIntroduced
Finn Sawyer Access to Cancer Testing Act
Introduced: Oct 21, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
Amends Medicare, Medicaid, and CHIP to provide coverage for advanced cancer diagnostic and laboratory tests including genomic sequencing.
Key Points
- 1Adds coverage for microarray analysis, DNA/RNA sequencing, and whole-exome sequencing for cancer patients
- 2Requires explanation and interpretation services to be covered
- 3Limits testing to once per diagnosis, once per recurrence, and as needed for treatment planning
- 4Sets Medicare payment at 80% (or 100% for assignment cases) of lesser of actual charge or clinical lab rate
- 5Mandates coverage in Medicaid and CHIP programs
- 6Establishes education program on genomic testing for physicians and public
Impact Areas
Cancer patientsOncologists and healthcare providersMedicareMedicaidChildren's Health Insurance ProgramClinical laboratories
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025